| II-11 S. Y. Amy Cheung Exposure-Response Analysis of Tovorafenib (DAY101) Relating Objective Response to Exposure, Patient- and Disease Characteristics Wednesday 15:10-16:40 |
| II-11 S. Y. Amy Cheung Exposure-Response Analysis of Tovorafenib (DAY101) Relating Objective Response to Exposure, Patient- and Disease Characteristics Wednesday 15:10-16:40 |